HEALIXA INC - EMOR STOCK NEWS

Healixa, Inc. (OTC Pink: EMOR) has secured an order indication for 1,500 units of its Global AquaDuct™ from WATERisLIFE, worth approximately $22,500,000. This adds to an existing $15,000,000 in order indications, totaling $37,500,000. Each unit can produce around 113.48 million liters of water annually. The demand for Global AquaDuct™ is rising in South America, which faces significant water insecurity issues. Healixa also signed a supply agreement with Solar Integrated Roofing Corp for solar components for the units, reflecting a strong partnership to address clean water needs.

Healixa, Inc. (OTC Pink: EMOR) announced an order indication from WATERisLIFE for 1,000 units of its Global AquaDuct™, representing approximately $15 million in pre-sales. These units will provide about 75.65 million liters of clean water annually, aimed at addressing water scarcity in Central America. The company also highlighted the pressing need for clean water in the region, noting that contamination affects 90% of water supplies in Guatemala. Healixa's advanced technology utilizes solar power to generate potable water sustainably.

Healixa, Inc. (OTC Pink: EMOR) has announced a supply agreement with Solar Integrated Roofing Corp. (OTC Pink: SIRC) for components of its Global Aquaduct devices, utilizing the company's Atmospheric Water Harvesting technology. As part of this agreement, shareholders of each company will exchange 100 shares. Healixa aims to provide potable water sustainably, estimating that solar components will constitute 2.5% of production costs. The partnership is expected to drive mass production and enhance the capabilities of Healixa's innovative clean water solutions.

Healixa, Inc. (OTC: EMOR) has initiated its pre-order process for the Global Aquaduct™, a unit utilizing the company's proprietary Atmospheric Water Harvesting™ technology. The Global Aquaduct™ is designed to provide potable water harvested directly from the atmosphere, capable of producing several hundreds of liters daily with minimal energy usage. These units are aimed at government agencies and non-profit organizations seeking efficient and sustainable clean water solutions. Healixa anticipates strong interest based on feedback from potential customers.

Healixa, a technology firm specializing in health-tech, clean water, and green-tech, announces the appointment of Richard Alloway II to its Advisory Board, effective immediately. This move highlights the company's commitment to sustainable communities through innovative technologies. Alloway, a former Pennsylvania State Senator, aims to leverage his political experience to guide Healixa in deploying its technologies effectively within the state. CEO Ian Parker emphasized Alloway's insight as invaluable for bridging technology and local government needs.

Healixa, Inc. (OTC Pink: EMOR) has appointed Diane Koontz to its Advisory Board, effective immediately. Koontz, currently President of Managed Health Care Associates, Inc., brings over 25 years of experience in the health care industry, having held various leadership roles. Her expertise will support Healixa's growth strategy particularly in the underserved independent pharmacies market. CEO Ian Parker emphasized that her appointment signifies a commitment to strengthening Healixa's healthtech portfolio, which focuses on innovative technologies in health-tech, clean water, and green-tech sectors.

Healixa, Inc. (OTC Pink: EMOR) announces the appointment of Christopher Galliano as a non-executive independent Director, enhancing corporate governance and growth strategy. With extensive experience in defense-related projects and a background in AI-driven drug discovery, Galliano's role aims to support Healixa's focus on innovative technologies in health-tech and green-tech. This appointment brings the company closer to meeting national listing requirements for an exchange such as NASDAQ. The outgoing Board member, John Lee, will continue as Chief Financial Officer.

Healixa, Inc. (OTC Pink: EMOR) has appointed former U.S. Representative Denver Riggleman to its Board of Directors. Riggleman, an Air Force veteran and national security expert, anticipates contributing to Healixa’s mission of developing innovative technologies in health-tech and green-tech. CEO Ian Parker expressed excitement about Riggleman's diverse expertise, which is deemed essential for the company's growth as it prepares to advance in public markets. The announcement also acknowledges Matthew Dill's departure from the Board, thanking him for his service while highlighting Riggleman's expected value addition.

Healixa, Inc. (OTC Pink: EMOR) announces that CEO Ian Parker will present in a live webinar at the Skyline Signature Series on December 8, 2021, at 12 PM ET. This event allows investors to engage directly with the company. Healixa focuses on innovative technologies in health-tech, clean water, and green-tech sectors.

Pre-registration is required for participation. The Skyline Signature Series serves as a platform for public companies to connect with financial professionals effectively.